Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer by Lidia Moyano‐Galceran, Elina A Pietilä, S Pauliina Turunen, Sara Corvigno, Elisabet Hjerpe, Daria Bulanova, Ulrika Joneborg, Twana Alkasalias, Yuichiro Miki, Masakazu Yashiro, Anastasiya Chernenko, Joonas Jukonen, Madhurendra Singh, Hanna Dahlstrand, Joseph W Carlson, Kaisa Lehti

Get full text

Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer by Sara Corvigno, Jun Yao, Amma Asare, Li Zhao, Joseph Celestino, Richard A. Hajek, Ency A. Arboleda Goette, Ridge T. Rogers, Raymond N. Montoya, Ping Song, Qingxiu C. Zhang, Xingzhi Song, Mohammad M. Mohammad, Kenna R. Shaw, Jianhua Zhang, Karen H. Lu, Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Sanghoon Lee

Get full text

The dynamic immune behavior of primary and metastatic ovarian carcinoma by Elaine Stur, Fuduan Peng, Pang-ning Teng, Emine Bayraktar, Min Hu, Sara Corvigno, David J. Brown, Sanghoon Lee, Kathleen N. Moore, Nicholas W. Bateman, Kathleen M. Darcy, George L. Maxwell, Thomas P. Conrads, Nidhi Sahni, Ignacio Vázquez-García, Sohrab P. Shah, Joseph Celestino, Nicole D. Fleming, Nicholas E. Navin, Linghua Wang, Anil K. Sood

Get full text